Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Malignant Bladder Neoplasm+26.6Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Esophageal Neoplasm+3.4Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0Malignant Salivary Gland Neop…0Malignant Testicular Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42181
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2598619

2=Malignant Bladder Neoplasm+26.696.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15014
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
73.3
activityPercentile
46.7

ranking row 2598620

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9128
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2598621

4=Malignant Laryngeal Neoplasm+2090Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3732
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2598622

5=Malignant Pancreatic Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
37344
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2598623

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
428
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2598624

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1022
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2598625

8=Malignant Esophageal Neoplasm+3.476.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14446
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2598626

9=Malignant Kidney Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13559
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2598628

9=Malignant Mesothelioma+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2651
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2598627

11=Malignant Lung Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
156953
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2598629

11=Malignant Prostate Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
27970
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2598631

11=Malignant Rectal Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9602
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2598633

11=Malignant Salivary Gland Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
820
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
16.7
activityPercentile
16.7

ranking row 2598630

11=Malignant Testicular Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
380
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2598632

16=Malignant Liver Neoplasm-3.350Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21608
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
80
activityPercentile
83.3

ranking row 2598634

16=Malignant Thyroid Gland Neoplasm-3.350Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1747
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2598635

18=Malignant Anal Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
863
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
20
activityPercentile
23.3

ranking row 2598636

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41374
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2598637

20=Malignant Hypopharyngeal Neoplasm-6.736.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
322
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2598638

20=Malignant Penile Neoplasm-6.736.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
239
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2598639

22=Leukemia-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23194
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
83.3
activityPercentile
90

ranking row 2598640

22=Malignant Central Nervous System Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14491
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
70
activityPercentile
76.7

ranking row 2598641

22=Malignant Ovarian Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14346
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
63.3
activityPercentile
70

ranking row 2598642

25=Hodgkin Lymphoma-1020Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1168
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
26.7
activityPercentile
36.7

ranking row 2598643

26=Malignant Gastric Neoplasm-13.416.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11035
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
53.3
activityPercentile
66.7

ranking row 2598644

27=Malignant Uterine Corpus Neoplasm-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3714
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2598647

27=Multiple Myeloma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11411
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56.7
activityPercentile
73.3

ranking row 2598645

27=Non-Hodgkin Lymphoma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20317
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2598646

30=Malignant Cervical Neoplasm-16.73.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4092
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2598648

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
630
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2598649

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 954f3d6277fb067c07a4b05e